share_log

TC BioPharm To Begin Proof Of Concept Preclinical Studies For Lead Therapy TCB008 To Treat Monkeypox; Aims To Partner With Infectious Disease Center For Rapid Advancement Of Studies

TC BioPharm To Begin Proof Of Concept Preclinical Studies For Lead Therapy TCB008 To Treat Monkeypox; Aims To Partner With Infectious Disease Center For Rapid Advancement Of Studies

TC BioPharm將開始進行概念性臨床前研究,以治療天花的主要療法TCB008;旨在與傳染病中心合作,快速推進研究。
Benzinga ·  09/06 16:02

TC BioPharm To Begin Proof Of Concept Preclinical Studies For Lead Therapy TCB008 To Treat Monkeypox; Aims To Partner With Infectious Disease Center For Rapid Advancement Of Studies

TC BioPharm將開始進行概念性臨床前研究,以治療天花的主要療法TCB008;旨在與傳染病中心合作,快速推進研究。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論